| Product |
CAS |
Molecular formula |
More |
| 1-{4-[(1-Cyclobutylpiperidin-4-ylidene)methyl]phenyl}propan-2-one |
1425972-03-7 |
C19H25NO |
More |
| 4-(4-Bromobenzylidene)-1-(cyclopropylmethyl)piperidine |
1425971-96-5 |
C16H20BrN |
More |
| 4-(4-Bromobenzylidene)-1-(propan-2-yl)piperidine |
1425971-92-1 |
C15H20BrN |
More |
| 4-(4-Bromobenzylidene)-1-cyclopentylpiperidine |
1425971-89-6 |
C17H22BrN |
More |
| 4-(1H-pyrazol-1-yl)cyclohexanone |
1425971-78-3 |
C9H12N2O |
More |
| 4-(4-Bromobenzylidene)-1-cyclobutylpiperidine |
1425970-11-1 |
C16H20BrN |
More |
| Tert-butyl 4-{4-[(acetyloxy)(cyclopentyl)methyl]benzylidene}piperidine |
1425971-37-4 |
C25H35NO4 |
More |
| Tert-butyl 4-{4-[cyclopentyl(hydroxy)methyl]benzylidene}piperidine-1-c |
1442691-87-3 |
C23H33NO3 |
More |
| 1-(4-((1-Cyclobutylpiperidin-4-ylidene)methyl)phenyl)-2-cyclopropyleth |
1425971-35-2 |
C21H29NO |
More |
| 1-(4-((1-Cyclobutylpiperidin-4-ylidene)methyl)phenyl)-2-cyclopentyleth |
1425971-34-1 |
C23H33NO |
More |
| 2-(4-((1-Cyclobutylpiperidin-4-ylidene)methyl)phenyl)propan-2-ol |
1425971-31-8 |
C19H27NO |
More |
| (4-((1-Cyclobutylpiperidin-4-ylidene)methyl)phenyl)methanol |
1425971-30-7 |
C17H23NO |
More |
| 4-[(1-Ethylpiperidin-4-ylidene)methyl]benzaldehyde |
1425971-24-9 |
C15H19NO |
More |
| Tert-butyl 4-[4-(piperidin-1-ylmethyl)benzylidene]piperidine-1-carboxy |
1425971-17-0 |
C23H34N2O2 |
More |
| 3-[(4-{[1-(Tert-butoxycarbonyl)piperidin-4-ylidene]methyl}benzyl)oxy]- |
1425971-14-7 |
C22H26N2O6 |
More |
| Tert-butyl 4-[4-({[5-(methoxycarbonyl)-1,2-oxazol-3-yl]oxy}methyl)benz |
1425971-13-6 |
C23H28N2O6 |
More |
| Tert-butyl 4-(4-{[5-(methoxymethyl)-2-oxopyridin-1(2h)-yl]methyl}benzy |
1425970-90-6 |
C25H32N2O4 |
More |
| Tert-butyl 4-(4-{[5-(hydroxymethyl)-2-oxopyridin-1(2h)-yl]methyl}benzy |
1425970-89-3 |
C24H30N2O4 |
More |
| Tert-butyl 4-{4-[(5-formyl-2-oxopyridin-1(2h)-yl)methyl]benzylidene}pi |
1425970-88-2 |
C24H28N2O4 |
More |
| Tert-butyl 4-{4-[(3-methoxy-2-oxopyridin-1(2h)-yl)methyl]benzylidene}p |
1425970-78-0 |
C24H30N2O4 |
More |
